Noom partners with Liviniti on Noom’s newest offering: Noom GLP-1 Companion

Digital healthcare company Noom has partnered with Liviniti, a national pharmacy benefit manager (PBM), to introduce a comprehensive metabolic offering for plan sponsors and employees. The collaboration includes Noom Weight, Noom Diabetes Prevention Program, and the newly launched Noom GLP-1 Companion. 

Designed for individuals taking GLP-1s for weight loss, the program assists members through various phases of their weight loss journey, offering support in nutrition, exercise, medication adherence, and long-term weight maintenance. The GLP-1 Companion addresses challenges associated with GLP-1 use, such as muscle loss and potential weight regain, aiming to provide holistic treatment plans through coaching and content support.

Noom's GLP-1 Companion program integrates with pharmacy benefit manager prior authorisation processes, incorporates a tailored approach to food colour-coding for GLP-1 users, and features tools like a protein-tracking tool, fitness-focused lessons, and expert guidance on side effects and complications. Liviniti, as a pioneer in pharmacy benefit innovation, is the first PBM to collaborate with Noom in optimising weight management outcomes with the GLP-1 Companion. The program is set to be available to Liviniti clients and their members from March 2024.

Noom's CEO Geoff Cook expressed the company's commitment to delivering a comprehensive GLP-1 course of care, emphasising the importance of lifestyle in GLP-1 success. Noom has been involved in GLP-1 companion support since 2018, and the GLP-1 Companion program builds on the success of an earlier GLP-1 program, engaging over 65,000 users. Additionally, Liviniti clients seeking stress and mental wellness support for their members can access Noom's stress management program, Noom Mood, as part of the collaboration.